Case Report Describes Loss of Vision After Popper Inhalation

Share this content:
Case Report Describes Loss of Vision After Popper Inhalation
Case Report Describes Loss of Vision After Popper Inhalation

TUESDAY, March 8, 2016 (HealthDay News) -- Inhalation of "poppers," a group of alkyl nitrite chemicals, which cause euphoria, sexual arousal, and relaxation of smooth muscles, can cause disruption in vision, according to a case report published online March 7 in BMJ: Case Reports.

Joshua Luis, from the Hairmyres Hospital in East Kilbride, U.K., and colleagues describe the case of a 52-year-old man with sudden, bilateral central loss of vision. The patient presented to the ophthalmology acute referral clinic with a 10-day history of central visual blurring and metamorphopsia. The deterioration started immediately following a night of clubbing, during which the patient inhaled poppers.

The researchers found that the patient had unremarkable slit-lamp examination, with normal fundus views. His best corrected visual acuity was 6/15 and 6/12 in the left and right eyes, improving to 6/12 and 6/9.5, respectively, with pinhole. Pupil reactions and color vision were found to be normal. Disruption of the inner and outer segment layers were seen on spectral domain optical coherence tomography (OCT), which was confined to the fovea. Both eyes had identical findings. The patient was treated conservatively, and best corrected visual acuity improved to 6/9.5 bilaterally at three-month follow-up. There was some improvement in the photoreceptor layer on OCT, although mild changes in the foveal area persisted.

"Differential diagnoses for poppers retinopathy include photic injury, central serous retinopathy, and vitreoretinal traction," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »